Sun Pharmaceuticals Industries and Ranbaxy , came through earlier this week ..... positive on the merger, as we believe Ranbaxy 's OTC and specialty drugs portfolio ..... are also present in the acquired Ranbaxy business. We believe the stock is
(Adds details from CCI order, comments from Sun and Ranbaxy , background)
MUMBAI, Dec 8 (Reuters) - India's antitrust regulator said on Monday it has approved generic drugmaker Sun Pharmaceutical Industries Ltd's $3.2 billion bid to buy smaller rival Ranbaxy Laboratories Ltd , subject to the companies divesting seven products.
Dec 5 (Reuters) - A Massachusetts jury has found that an agreement between AstraZeneca Plc and Ranbaxy Laboratories Ltd to delay the launch of a generic version of AstraZeneca's heartburn drug Nexium...
* Ranbaxy says sees no significant impact on business (Recasts with statements from Ranbaxy and European regulator, adds details)
MUMBAI, Dec 3 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd has been barred by from exporting the antibiotic cephalosporin to Germany from its plant in central India for not complying with standard manufacturing practices.
(Adds Endo's launch of generic Valcyte and Dr. Reddy's comment)
Nov 20 (Reuters) - A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court filing showed.
* Ranbaxy alleges FDA's move violated constitutional rights
MUMBAI, Nov 18 (Reuters) - Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the Indian firm to launch copies of two drugs including AstraZeneca Plc's heartburn pill Nexium, court documents showed.